CureVac files patent lawsuit in Germany against BioNTech over mRNA technology
CureVac files patent lawsuit in Germany against BioNTech over mRNA technology
Stay updated with breaking news from Iontech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CureVac files patent lawsuit in Germany against BioNTech over mRNA technology
University Health will be hosting vaccination clinics for kids ages 6 months to 5 years old every Tuesday and Thursday until demand is met.
NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) and BioNTech SE (BNTX) have reached a new supply agreement with the U.S. government to provide additional doses of COVID-19 Vaccine, the companies said
Pfizer Inc. and partner BioNTech said on Wednesday they signed a $3.2 billion deal with the U.S. government for 105 million doses of their COVID-19 vaccine.
Pfizer and BioNTech Announce New Agreement with U.S. Government to Provide Additional Doses of COVID-19 Vaccine •105 million 30 µg, 10 µg and 3... | June 30, 2022